ProfileGDS5822 / ILMN_1222231
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 95% 96% 95% 95% 96% 94% 97% 96% 95% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11184.495
GSM1276600PDAC Late Ablation Control 21617.996
GSM1276601PDAC Late Ablation Control 31208.695
GSM1276602PDAC Late Ablation 11089.995
GSM1276603PDAC Late Ablation 21402.896
GSM1276604PDAC Late Ablation 31125.994
GSM1303940PDAC Late Ablation_anti-CTLA4 11799.897
GSM1303941PDAC Late Ablation_anti-CTLA4 21518.196
GSM1303942PDAC Late Ablation_anti-CTLA4 31385.295